Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioma Glioblastoma Multiforme”

2,047 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,047 results

Not applicableTemporarily pausedNCT06129760
What this trial is testing

Glioblastoma Remote Monitoring and Care - Research Protocol

Who this might be right for
GlioblastomaVenous ThromboembolismSeizures
Case Comprehensive Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00050986
What this trial is testing

Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
M.D. Anderson Cancer Center 55
Not applicableUnknownNCT05772741
What this trial is testing

Grafts of GSCs Into Brain Organoids for Testing Anti-invasion Drugs

Who this might be right for
GlioblastomaGlioma, Malignant
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 160
Testing effectiveness (Phase 2)Looking for participantsNCT06059690
What this trial is testing

Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells

Who this might be right for
Glioblastoma MultiformeGlycolytic IndexEpidermal Growth Factor Receptor
Jonsson Comprehensive Cancer Center 50
Early research (Phase 1)Ended earlyNCT02168270
What this trial is testing

Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligodendrogliomaAnaplastic Oligoastrocytoma+2 more
University of Nebraska 4
Testing effectiveness (Phase 2)Study completedNCT00004937
What this trial is testing

Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Early research (Phase 1)Looking for participantsNCT06815029
What this trial is testing

Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma

Who this might be right for
Recurrent Astrocytoma, IDH-Mutant, Grade 3Recurrent Astrocytoma, IDH-Mutant, Grade 4Recurrent Glioblastoma
City of Hope Medical Center 27
Large-scale testing (Phase 3)Study completedNCT00304031
What this trial is testing

Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 1,173
Not applicableStudy completedNCT04730869
What this trial is testing

Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma

Who this might be right for
Glioblastoma
Waikato Hospital 18
Testing effectiveness (Phase 2)Looking for participantsNCT04573192
What this trial is testing

Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression

Who this might be right for
Glioblastoma
Philogen S.p.A. 142
Not applicableNot Yet RecruitingNCT07492836
What this trial is testing

Hypofractionated Radiotherapy Plus Temozolamide in Patients Younger Than 70 Years With Glioblastoma

Who this might be right for
Glioblastoma (GBM)
Hospital do Coracao 10
Large-scale testing (Phase 3)Not Yet RecruitingNCT07349693
What this trial is testing

Comparison of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma, IDH-Wildtype
Everfront Biotech Co., Ltd. 175
Early research (Phase 1)Not Yet RecruitingNCT07492316
What this trial is testing

RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)

Who this might be right for
Recurrent Medulloblastoma
University of Florida 24
Not applicableStudy completedNCT01009307
What this trial is testing

Study of Blood and Cheek Cell Samples From Patients With Glioma

Who this might be right for
Brain and Central Nervous System Tumors
University of California, San Francisco 1,709
Testing effectiveness (Phase 2)Study completedNCT00352521
What this trial is testing

Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 20
Not applicableNot Yet RecruitingNCT07029100
What this trial is testing

Feasibility of ORGAnoids in Routine Clinical Practice for Molecular Analysis of the GLIOvascular Niche in Patients With Primary Brain Tumors.

Who this might be right for
Glioblastoma
Centre Henri Becquerel 30
Testing effectiveness (Phase 2)WithdrawnNCT06328036
What this trial is testing

Testing the Combination of Anti-cancer Drugs Tiragolumab and Atezolizumab to Improve Outcomes for Patients With Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma, IDH-Wildtype
National Cancer Institute (NCI)
Not applicableStudy completedNCT03439332
What this trial is testing

Multicentre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of the Patient With Glioblastoma

Who this might be right for
Glioblastoma
Juan M Garcia-Gomez 305
Early research (Phase 1)Ended earlyNCT04397679
What this trial is testing

Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
Barbara Ann Karmanos Cancer Institute 2
Large-scale testing (Phase 3)Active Not RecruitingNCT02685605
What this trial is testing

Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma
Universitätsmedizin Mannheim 314
Load More Results